Evidence map›Paper›PMID 24283977›Full record

ArticleACS chemical biology2014

Cupric yersiniabactin is a virulence-associated superoxide dismutase mimic.

Kaveri S Chaturvedi, Chia S Hung, Daryl E Giblin, Saki Urushidani, Anthony M Austin, Mary C Dinauer, Jeffrey P Henderson

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
7.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Non-classical roles of bacterial siderophores in pathogenesis.Frontiers in cellular and infection microbiology · 2024
    Review
  11. Article
  12. UropathogenicbioRxiv : the preprint server for biology · 2023
    Article
  13. Review
  14. ThemBio · 2022
    Article
  15. "Omics" Technologies - What Have They Told Us About UropathogenicFrontiers in cellular and infection microbiology · 2022
    Review
  16. Review
  17. Article
  18. Antimicrobial Activity of Metals and Metalloids.Annual review of microbiology · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kaveri S ChaturvediCenter for Women's Infectious Diseases Research, ‡Division of Infectious Diseases, §Department of Internal Medicine, ∥Department of Chemistry, ⊥Department of Pediatrics, and #Department of Pathology and Immunology, Washington University School of Medicine , St. Louis, Missouri 63110, United States.
Chia S Hung
Daryl E Giblin
Saki Urushidani
Anthony M Austin
Mary C Dinauer
Jeffrey P Henderson

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Jonathan R Brestoff · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
TRANSGENICS COREP60DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 1986 to 2012
$25.2M
pan-Genome of E.coli in the bladder and gut of women with recurrent UTIP50DK064540 · NIDDK · WASHINGTON UNIVERSITY · PI HULTGREN, SCOTT J. · 2002 to 2017
$17.9M
YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTSP41RR000954 · NCRR · WASHINGTON UNIVERSITY · PI LIN, XI · 1985 to 2011
$16.0M
INTERDISCIPLINARY RESEARCH CAREERS IN WOMEN'S HEALTHK12HD001459 · NICHD · WASHINGTON UNIVERSITY · PI SEMENKOVICH, CLAY F. · 2000 to 2014
$6.9M
Faculty Recruit for Washington University Diabetic Cardiovascular Disease CenterP30HL101263 · NHLBI · WASHINGTON UNIVERSITY · PI SCHAFFER, JEAN E. · 2009 to 2010
$1.1M
NCRR NIH HHS P41 RR000954NCRR NIH HHS P41-RR00954NHLBI NIH HHS P30 HL101263NHLBI NIH HHS P30 HL101263-01NICHD NIH HHS K12 HD001459NICHD NIH HHS K12 HD001459-09NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK056341NIDDK NIH HHS P50 DK064540NIDDK NIH HHS P60 DK020579NIDDK NIH HHS P60-DK20579
6 · The paper itself

Abstract

Many Gram-negative bacteria interact with extracellular metal ions by expressing one or more siderophore types. Among these, the virulence-associated siderophore yersiniabactin (Ybt) is an avid copper chelator, forming stable cupric (Cu(II)-Ybt) complexes that are detectable in infected patients. Here we show that Ybt-expressing E. coli are protected from intracellular killing within copper-replete phagocytic cells. This survival advantage is highly dependent upon the phagocyte respiratory burst, during which superoxide is generated by the NADPH oxidase complex. Chemical fractionation links this phenotype to a previously unappreciated superoxide dismutase (SOD)-like activity of Cu(II)-Ybt. Unlike previously described synthetic copper-salicylate (Cu(II)-SA) SOD mimics, the salicylate-based natural product Cu(II)-Ybt retains catalytic activity at physiologically plausible protein concentrations. These results reveal a new virulence-associated adaptation based upon spontaneous assembly of a non-protein catalyst.

Indexed as

Host-Pathogen InteractionsAnimalsCell LineChelating AgentsCopperEscherichia coliEscherichia coli InfectionsMacrophagesMicePhenolsSiderophoresSuperoxide DismutaseThiazolesChelating AgentsCopperPhenolsSiderophoresSuperoxide DismutaseThiazolesyersiniabactin

Identifiers

PMID24283977
PMCPMC3934373
OpenAlexW1991058591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.